Our people

"What drives me the most is solving difficult problems, in collaboration with others, for the benefit of the patient and the business."

Mark Fielding, Associate Principal Scientist, Global Medicines Development

View Mark's profile

Our people

"There is an expanding universe of biological data available which can revolutionise our understanding of disease and therapy if we find innovative ways to share and explore it."

Jonathan Dry, Principal Scientist, Bioinformatics, Oncology, IMED Biotech Unit

View Jonathan's profile

Our people

"I believe personalised healthcare is the future of medicine; it allows us to use the latest diagnostic science to target medicines to patients most likely to benefit."

Ruth March, Senior Vice-President of Precision Medicine and Genomics, IMED Biotech Unit

View Ruth's profile

David Berman

Head of Immuno-oncology Franchise

Rene van der Merwe

Vice President, Clinical Respiratory

Tom Keith-Roach

Therapy Area Vice President, Respiratory

Colin Reisner

Head, Respiratory Global Medicines, AstraZeneca and CEO of Pearl Therapeutics

Maria Belvisi

Vice President and Head, RIA Innovative Medicines

Ralph Knöll

Chief Scientist, IMED CVRM

David Keeling

Project Director, Respiratory, Inflammation & Autoimmunity, IMED Biotech Unit

Katerina Pardali

Associate Principal Scientist, Respiratory, Inflammation & Autoimmunity, IMED Biotech Unit

Roland Kolbeck

PhD, VP, R&D Respiratory, Inflammation and Autoimmunity (RIA)

Stephen Delaney

Associate Director, Respiratory, Inflammation & Autoimmunity, IMED Biotech Unit

Benoit Destenaves

Director, Molecular Diagnostics Labs and Pharmacogenomics, IMED Biotech Unit

Mark Fielding

Associate Principal Scientist, Global Medicines Development

Regina Fritsche-Danielson

Vice President and Head of Cardiovascular, Renal and Metabolism, IMED Biotech Unit

Jonathan Dry

Principal Scientist, Bioinformatics, Oncology, Innovative Medicines & Early Development

View Jonathan's profile

Ruth March

Vice-President and Head of Personalised Healthcare and Biomarkers, IMED Biotech Unit

View Ruth's profile

Li-Ming Gan

Medical Science Director, Early Clinical Development (Cardiovascular and Metabolism), IMED Biotech Unit

Shaun Grady

Vice-President Business Development Operations

Maria Groves

Associate Director, Head of the CRUK MedImmune Alliance Laboratory (CMAL)

Bahija Jallal

President, MedImmune and Executive Vice President, AstraZeneca

William Dall’Acqua

Senior Director, R&D, Antibody Discovery and Protein Engineering, MedImmune

Biljana Naumovic

Country President, Switzerland

Mark O’Connor

Chief Scientist, Oncology, IMED Biotech Unit

Slavé Petrovski

Vice-president and Head of Genome Analytics for AstraZeneca Centre for Genomics Research (CGR), Cambridge, UK

Jane Osbourn

Vice-President Research and Development, MedImmune

View Jane's profile

Menelas Pangalos

Executive Vice-President, IMED Biotech Unit

View Menelas's profile

Elisa Lázaro Ibáñez

Postdoctoral Researcher -  IMED Biotech Unit, AstraZeneca Gothenburg

Per Lindblom

Global Products Manager, GMD - Cardiovascular, Renal and Metabolic Diseases

Project Lead, IMED Biotech unit - Cardiovascular, Renal and Metabolic Diseases

Ella Ekholm

Senior Medical Lead, Cardiovascular, Renal and Metabolism, Global Medicines Development (GMD) - Gothenburg

Ramon Mogueras

Regional Director EMEA, Global Real Estate

Kumar Srinivasan

Vice-President, Scientific Partnering and Alliances, IMED Biotech Unit and Site Head, R&D Boston

Helen Angell

Principal Scientist, Oncology, Translational Sciences, IMED Biotech Unit

Emma Dean

Director, Early Phase Oncology, Early Clinical Development, IMED Biotech Unit

Amy Taylor

Associate Director, Strategic Planning and Operations, Early Clinical Development, IMED Biotech Unit and Chair of the Network of Women UK

Christopher J. Rhodes

VP, Cardiovascular & Metabolic Disease Research, MedImmune

Nicolas Jose Guzman

Director, Nephrology Clinical Research; CVMD US Group Director

David Wilson

Senior Director and Global Head of Oncology Chemistry, IMED Biotech Unit

Leila Khoja

PhD, Associate Director Physician in AstraZeneca’s Clinical Discovery Unit (CDU), Cambridge, UK

Paul Harper

Associate Principal Scientist, Discovery Sciences, IMED Biotech Unit

Dónal Landers

Senior Director Physician OncTMU Early Clinical Development Clinical Leader – iDecide Programme, CRUK Manchester Institute

Herren Wu

Chief Technology Officer and Global Head of Antibody Discovery and Protein Engineering (ADPE), MedImmune

Our focus areas

Cardiovascular, Renal and Metabolism

Oncology

Respiratory

Inflammation and Autoimmunity

Neuroscience

Infection and Vaccines